Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Characteristics of Practical Op Amps01:16

Characteristics of Practical Op Amps

881
A difference amplifier, a crucial component in numerous electronic devices, ideally amplifies only the difference-mode signal, which is the difference between two input signals. However, in practical circuits, the output voltage depends on both the differential gain and the common-mode gain.
The ratio of differential gain to the common-mode gain is defined as the common-mode rejection ratio (CMRR). This ratio quantifies the ability of operational amplifiers (op-amps) to reject common-mode...
881
Theoretical Foundations of Nursing Practice01:30

Theoretical Foundations of Nursing Practice

18.0K
Theories play an essential role in organizing patient care. Theories refer to a proposed or followed belief, policy, or procedure that is the basis for action. Nursing theories are knowledge-based concepts that guide nurses' actions, influence nursing education and practice, and allow nurses to care for their patients.
Theories provide a perspective to assess patients' conditions and organize data and methods. They also assist in analyzing and interpreting information. They represent a...
18.0K
Equivalent Circuits for Practical Transformers01:28

Equivalent Circuits for Practical Transformers

1.4K
The practical equivalent circuits of single-phase two-winding transformers exhibit significant deviations from their idealized versions due to the inherent properties of winding resistance and finite core permeability. These properties result in real and reactive power losses, affecting the transformer's performance. Understanding these deviations is crucial for designing more efficient transformers.
In a practical transformer, each winding exhibits resistance and leakage reactance. The...
1.4K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advancing human ovarian biology in tandem with clinical care: considerations for collecting ovarian tissue for research after oophorectomy for tissue cryopreservation.

Frontiers in endocrinology·2026
Same author

Following the mobile genome: plasmids as a missing layer in surveillance of carbapenemase-producing Enterobacterales.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

A decade of <i>Streptococcus pneumoniae</i> bloodstream infections: a single-center retrospective analysis.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2026
Same author

Surveillance of carbapenemase-producing organisms - considering the practical and local implications of current surveillance processes.

The Journal of hospital infection·2026
Same author

Impact of a Perinatal Psychiatry Access Program on Patient Experience: A Cross-Sectional Study.

Psychiatric services (Washington, D.C.)·2026
Same author

Is the pneumococcal urinary antigen test still fit for purpose? a decade of experience.

Diagnostic microbiology and infectious disease·2026

Related Experiment Video

Updated: Feb 15, 2026

Methods for Comparing Nutrients in Beebread Made by Africanized and European Honey Bees and the Effects on Hemolymph Protein Titers
08:42

Methods for Comparing Nutrients in Beebread Made by Africanized and European Honey Bees and the Effects on Hemolymph Protein Titers

Published on: March 17, 2015

11.2K

European Practice for CDI Treatment.

Fidelma Fitzpatrick1,2, Mairead Skally3, Melissa Brady3

  • 1Department of Clinical Microbiology, The Royal College of Surgeons in Ireland, Dublin, Ireland. fidelmafitzpatrick@rcsi.ie.

Advances in Experimental Medicine and Biology
|February 1, 2018
PubMed
Summary

Clostridium difficile infection (CDI) treatment is evolving, with newer agents and fecal microbiota transplantation (FMT) showing promise. Current European guidelines offer diverse treatment options, but implementation and access to novel therapies vary across countries.

Keywords:
Anti-CDI agentsC. difficile prophylaxisC. difficile treatmentCDI guidelinesNovel C. difficile agents

More Related Videos

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.4K
Handling and Treatment of Male European Eels Anguilla anguilla for Hormonal Maturation and Sperm Cryopreservation
08:24

Handling and Treatment of Male European Eels Anguilla anguilla for Hormonal Maturation and Sperm Cryopreservation

Published on: January 28, 2018

8.2K

Related Experiment Videos

Last Updated: Feb 15, 2026

Methods for Comparing Nutrients in Beebread Made by Africanized and European Honey Bees and the Effects on Hemolymph Protein Titers
08:42

Methods for Comparing Nutrients in Beebread Made by Africanized and European Honey Bees and the Effects on Hemolymph Protein Titers

Published on: March 17, 2015

11.2K
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.4K
Handling and Treatment of Male European Eels Anguilla anguilla for Hormonal Maturation and Sperm Cryopreservation
08:24

Handling and Treatment of Male European Eels Anguilla anguilla for Hormonal Maturation and Sperm Cryopreservation

Published on: January 28, 2018

8.2K

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Clinical Medicine

Background:

  • Clostridium difficile infection (CDI) is a major global health concern causing significant illness and death.
  • Current standard treatments include metronidazole, vancomycin, and fidaxomicin, with metronidazole demonstrating lower efficacy.
  • European guidelines address various CDI scenarios, encompassing traditional antibiotics, newer agents, surgery, and non-antimicrobial options like fecal microbiota transplantation (FMT).

Purpose of the Study:

  • To review current Clostridium difficile infection (CDI) treatment strategies and guideline implementation across Europe.
  • To highlight the evolving landscape of CDI therapeutics, including novel agents and prophylactic measures.
  • To discuss challenges in recurrent CDI management and the development of alternative therapies.

Main Methods:

  • Analysis of European Society of Clinical Microbiology and Infectious Diseases (ESCMID) treatment guidelines for CDI.
  • Review of a 2017 survey on CDI guideline implementation and restrictions in 20 European countries.
  • Examination of ongoing research and clinical trials for novel anti-CDI agents, prophylaxis, and recurrent CDI treatments.

Main Results:

  • Most European countries have national CDI guidelines, but audited implementation is low (5 out of 14 countries).
  • Restrictions on new anti-CDI treatments are common (13 countries), involving approval processes or economic reviews.
  • Novel anti-CDI agents are in development, and prophylactic strategies (monoclonal antibodies, vaccines) are in advanced trials.

Conclusions:

  • Effective Clostridium difficile infection (CDI) management requires updated guidelines and improved implementation strategies.
  • Access to and adoption of newer, more effective CDI treatments remain a challenge in many European healthcare systems.
  • Future directions include novel therapeutics, prophylactic interventions, and advanced treatments for recurrent CDI, such as FMT and live biotherapeutics.